Buy KLOW Blend in Canada

KLOW is GLOW with a fourth peptide. Our KLOW Blend keeps the same GHK-Cu, BPC-157 and TB-500 core and adds KPV, with all four in one lyophilised vial. Here is what is in the vial, how it compares with GLOW, and how to buy KLOW Blend Canada-wide from Vistara Labs.

View product →

At a glance: Vistara Labs stocks the KLOW blend (GHK-Cu, BPC-157, TB-500 and KPV) in 80 mg vials and as a ready-mixed nasal spray, independently tested, with a certificate of analysis on our Lab Reports page, shipped from within Canada by Canada Post Xpresspost, with same-business-day dispatch on orders before 3 pm Pacific. We deliver to every province, including Ontario, Quebec, British Columbia and Alberta.

What is in a KLOW Blend vial

KLOW Blend brings four peptides together in a single vial and sits in our skin, tissue and inflammation research range. Here is the full composition.

What’s in the 80mg vial

• 50mg GHK-Cu
• 10mg BPC-157
• 10mg TB-500
• 10mg KPV

Each of the four has its own research literature, and together they cover related ground rather than the same ground:

• GHK-Cu: the copper tripeptide (glycine, histidine and lysine bound to copper), studied around collagen and elastin, skin renewal and tissue remodelling.
• BPC-157: Body Protection Compound, a fifteen amino acid peptide studied around soft tissue, tendon and ligament repair and the gut lining.
• TB-500: a synthetic peptide derived from thymosin beta-4, studied around cell migration and soft tissue repair.
• KPV: lysine, proline and valine, the last three amino acids of alpha-MSH, studied around inflammatory signalling in the gut and skin.

The appeal of the blend is practical: four peptides studied around connected processes, supplied together in one vial instead of four separate ones.

Why KLOW is sold by its 80mg total

A blend is sold by its total peptide mass. The 80mg on a KLOW Blend vial is the total across all four peptides, not 80mg of each. GLOW Blend follows the same convention: its 70mg is the total across three peptides, and the extra 10mg in KLOW is the KPV.

Within that total, GHK-Cu accounts for 50mg, so the copper peptide makes up most of the vial by mass, and the other three share the remaining 30mg in equal parts. That split is also why the powder carries a blue tint rather than arriving as a bone-white cake. GHK-Cu is a copper complex, and the colour comes from the copper itself, not from a dye.

Like most peptides, KLOW Blend is supplied freeze-dried, the format that keeps a peptide stable through shipping and storage. Unopened vials store well cold and dry until they are reconstituted.

KLOW or GLOW?

The two blends are one peptide apart. GLOW Blend is the GHK-Cu, BPC-157 and TB-500 trio, centred on skin and soft tissue research. KLOW keeps that trio and adds KPV, which carries the blend into inflammatory signalling and gut research as well.

KPV is only three amino acids long, and most of its research looks at the gut and skin, which makes it a natural fourth partner for a core already built around skin and tissue.

When the research calls for KPV alongside the GLOW core, KLOW puts all four peptides in a single vial instead of a GLOW vial plus a separate KPV vial. We have set the two blends side by side in KLOW vs GLOW.

KPV is also stocked on its own, as a lyophilised vial and as a pre-mixed nasal spray, and our KPV buying guide covers both formats.

Where to buy KLOW Blend Canada-wide

KLOW Blend is supplied for laboratory research use, and ordering it from us is simple. Here is what to expect.

• Four peptides in one vial. GHK-Cu, BPC-157, TB-500 and KPV are each listed with their milligrams on the product page, alongside the 80mg total.
• Single vial or a pack of ten. KLOW Blend is offered as a single vial and as a pack of ten vials, both on the same product page, so a larger project can be covered in one order.
• Lab reports. Certificates of analysis from independent laboratories are published for each compound on our lab reports page, with purity above 99 percent.
• Bacteriostatic water on the same order. We stock bacteriostatic water as well, so the vial and its diluent can arrive in the same parcel.
• Tracked, discreet delivery. Orders travel by tracked Canada Post to every province, in discreet packaging.
• Questions are welcome. A real person on our team answers email at [email protected], whether the question is about the blend, its components or an order.

Frequently asked questions

What is in KLOW peptide blend?

Four peptides in one lyophilised vial: 50mg GHK-Cu, 10mg BPC-157, 10mg TB-500 and 10mg KPV, 80mg in total.

What is the difference between KLOW and GLOW?

KLOW is the GLOW trio of GHK-Cu, BPC-157 and TB-500 with KPV added as a fourth peptide, which extends the blend into inflammatory signalling and gut research.

Why is KLOW Blend blue?

GHK-Cu is a copper complex and makes up most of the vial by mass, so the blue tint comes from the copper itself, not from a dye.

Can you buy KLOW Blend in Canada?

Yes, as a research material from Canadian peptide suppliers. Vistara Labs stocks it, and every order ships from within Canada, so there is no customs step.

Ready-mixed format. Also available as a pre-mixed nasal spray, with no reconstitution step: see our guide to buying a KLOW nasal spray in Canada.

References

No study of the KLOW blend as a complete formulation was identified. The references below cover its individual components.

1. Enhanced healing of ulcers in patients with diabetes by topical treatment with glycyl-l-histidyl-l-lysine copperMulder GD et al. · Wound Repair Regen 1994 · PMID 17147644Multicentre randomised, evaluator-blinded, placebo-controlled trial; topical GHK-Cu in diabetic neuropathic ulcers.
2. Intra-Articular Injection of BPC 157 for Multiple Types of Knee PainLee E et al. · Altern Ther Health Med 2021 · PMID 34324435Retrospective chart review, 17 patients (16 followed up by telephone); no control group, no blinding, no validated outcome instrument.
3. Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potentialEsposito S et al. · Drug Test Anal 2012 · PMID 22962027Analytical chemistry: characterises TB-500 as the N-terminally acetylated 17-23 fragment of thymosin β4 (Ac-LKKTETQ), not the intact 43-amino-acid protein.
4. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammationDalmasso G et al. · Gastroenterology 2008 · PMID 18061177Laboratory study in human intestinal epithelial cells and human T cells; no human exposure.

Links open the study record on PubMed so the source can be checked directly. Listing a study is not a claim that its findings apply to any other use, product or route of administration. Research use only.